Breakthrough Infections during Phase 1 and 2 Prime‐Boost HIV‐1 Vaccine Trials with Canarypox Vectors (ALVAC) and Booster Dose of Recombinant gp120 or gp160
Lee, Deborah, Graham, Barney S., Chiu, Ya‐Lin, Gilbert, Peter B., McElrath, M. Juliana, Belshe, Robert B., Buchbinder, Susan P., Sheppard, Haynes W., Koblin, Beryl A., Mayer, Kenneth H., Keefer, MichaТом:
190
Мова:
english
Журнал:
The Journal of Infectious Diseases
DOI:
10.1086/423284
Date:
September, 2004
Файл:
PDF, 332 KB
english, 2004
File converter
Більше результатів пошуку
More benefits 
